Sanofi traded at $41.19 this Thursday August 18th, decreasing $0.99 or 2.35 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 20.17 percent. Over the last 12 months, its price fell by 21.53 percent. Looking ahead, we forecast Sanofi to be priced at 42.77 by the end of this quarter and at 38.30 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
41.19
Daily Change
-2.35%
Yearly
-21.53%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 141.29 -0.15 -0.11% 19.81%
Amgen 249.70 -0.88 -0.35% 11.28%
AstraZeneca 11,014.00 12.00 0.11% 26.08%
Astrazeneca 66.50 0.08 0.12% 12.35%
Bristol-Myers Squibb 74.15 -0.41 -0.55% 8.23%
Corcept Therapeutics 27.46 0.45 1.67% 34.81%
Catalent 106.31 -2.09 -1.93% -12.07%
Endo International 0.41 0.12 42.90% -88.57%
Genmab 2,617.00 -39.00 -1.47% -11.86%
Galapagos 52.24 -0.72 -1.36% 7.59%
GlaxoSmithKline 1,402.00 -13.40 -0.95% -7.37%
Glaxosmithkline 34.25 -0.45 -1.30% -18.08%
Horizon Pharma 61.21 -0.52 -0.84% -40.71%
Jazz Pharmaceuticals 156.55 -1.05 -0.67% 19.04%
J&J 166.77 -0.81 -0.48% -6.61%
Lannett 0.57 -0.002 -0.28% -86.36%
Eli Lilly 316.72 -0.10 -0.03% 17.13%
Merck & Co 91.40 0.36 0.40% 16.49%
Novartis 81.10 -0.13 -0.16% -5.05%
Novartis 84.92 -0.30 -0.35% -8.88%
Phibro Animal Health 18.33 -0.12 -0.65% -25.79%
Prestige Brands 56.46 0.73 1.31% -2.62%
Pacira 58.12 -0.02 -0.03% 6.35%
Pfizer 48.58 -0.69 -1.40% -0.45%
Powershares High Yield Orate Bond Portfolio 17.68 0.02 0.11% -9.19%
Perrigo 41.02 1.39 3.51% 3.20%
Drreddys Laboratories 52.73 0.54 1.03% -15.75%
Roche Holding 319.95 3.30 1.04% -13.99%
Supernus Pharmaceuticals 33.86 0.35 1.04% 43.84%
Teva Pharmaceutical Industries 10.34 0.33 3.30% 12.15%
UCB 72.62 0.18 0.25% -26.87%
United States Oil Fund 74.21 2.16 3.00% 65.76%
Canopy Growth Corp 4.91 -0.32 -6.12% -76.80%
Zoetis 170.17 -2.29 -1.33% -17.57%


Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.